{"doi":"10.1039/d2md00163b","title":"Fragment optimization and elaboration strategies – the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits","abstract":"-deleted cancers. Starting with five fragment/PRMT5/MTA X-ray co-crystal structures, we employed a two-phase fragment elaboration process encompassing optimization of fragment hits and subsequent fragment growth to increase potency, assess synthetic tractability, and enable structure-based drug design. Two lead series were identified, one of which led to the discovery of the clinical candidate MRTX1719.","journal":"RSC Medicinal Chemistry","year":2022,"id":263818,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":13,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9121,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":844456,"name":"Svitlana Kulyk","orcid":"0000-0003-0346-3441","position":1,"is_corresponding":false},{"id":920915,"name":"Misbha Ud Din Ahmad","orcid":"0000-0002-4892-7337","position":2,"is_corresponding":false},{"id":920916,"name":"Valentina Arkhipova","orcid":"0000-0001-8345-665X","position":3,"is_corresponding":false},{"id":615203,"name":"James G. Christensen","orcid":"0000-0003-1835-0335","position":4,"is_corresponding":false},{"id":615192,"name":"Robin J. Gunn","orcid":"0000-0003-0865-0369","position":5,"is_corresponding":false},{"id":844453,"name":"Anthony Ivetac","orcid":"0000-0002-4174-6605","position":6,"is_corresponding":false},{"id":844454,"name":"John M. Ketcham","orcid":"0000-0001-5011-9593","position":7,"is_corresponding":false},{"id":845401,"name":"Jon Kuehler","orcid":null,"position":8,"is_corresponding":false},{"id":615195,"name":"J. David Lawson","orcid":"0000-0002-5232-4539","position":9,"is_corresponding":false},{"id":615200,"name":"Nicole C. Thomas","orcid":"0000-0002-7200-8015","position":10,"is_corresponding":false},{"id":615185,"name":"Xiaolun Wang","orcid":"0000-0001-9576-7746","position":11,"is_corresponding":false},{"id":615204,"name":"Matthew A. Marx","orcid":"0000-0003-2351-4787","position":12,"is_corresponding":false},{"id":615199,"name":"Christopher R. Smith","orcid":"0000-0002-6553-2791","position":0,"is_corresponding":true}],"reference_count":20,"raw_metadata":null,"created_at":"2026-07-19T00:26:33.413850Z","pmid":"36545438","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}